News

The US Food and Drug Administration (FDA) also granted orphan drug designation for ApoCell). Enlivex, a Hadasit Bio-Holdings portfolio company, intends to commence a Phase IIb / III

The open-label, randomized, controlled, global pivotal trial is enrolling patients with advanced primary, not yet treated, head and neck cancer. The trial’s main objective is to show a

OPN-305 is a new humanized IgG4 monoclonal antibody (MAb) against the Toll-Like Receptor 2 (TLR2), a target within the innate immune system. Evaluation of OPN-305 in MDS will

The company acquired Sivextro, as a part of its purchase through a subsidiary of Cubist Pharmaceuticals. Sivextro is a once-daily oxazolidinone antibiotic developed for both intravenous and oral

Alirocumab is an investigational monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). Under the Prescription Drug User Fee Act (PDUFA), the goal for a priority review is

Prestalia is the first fixed-dose combination of perindopril arginine and amlodipine, may be used in patients whose blood pressure is not adequately controlled on monotherapy. The drug may

Assistant professor of biochemistry and molecular biology at Saint Louis University Mee-Ngan F. Yap, Ph.D studied staph that had been treated with the antibiotic azithromycin. During the study

The Fast Track designation process of the FDA is designed to facilitate the development and expedite the review and approval of drugs intended to treat serious or life

"Retinal vein occlusion is a common retinal vascular disorder with an estimated 16.4 million people affected worldwide, and it is a severe disease which is potentially blinding if